Good Morning America
Independent FDA panel votes to authorize Moderna booster for seniors and high-risk Americans
An independent Food and Drug Administration advisory panel on Thursday voted unanimously to authorize Moderna Covid-19 vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus. The recommendation is in line with what the FDA and Centers for Disease Control and Prevention authorized for Pfizer booster shots last month. The Moderna booster will only be a half dose, as opposed to the full dose for Pfizer, but was found to return antibody protection to the initial levels after the first two shots.